Vetsys Pharmaceutical
Vetsys Pharmaceutical
Advanced pharmaceutical infusions designed for high-yield dairy herds.
Japan’s dairy sector, particularly in the Hokkaido region, is renowned globally for its rigorous quality standards and high-fat milk production. Bovine mastitis remains the leading economic challenge for Japanese farmers. Our intramammary infusions are formulated to meet these exacting standards, providing rapid recovery and minimal milk discard times.
Japan is at the forefront of the "One Health" approach, strictly regulating veterinary medicines. The demand for targeted treatments like Cefquinome Sulfate—a fourth-generation cephalosporin—is rising due to its high efficacy against multi-drug resistant pathogens common in modern Japanese dairy farms.
With an aging agricultural workforce, Japan is moving toward robotic milking systems. Our infusion tubes are designed for ergonomic, quick, and sterile application, fitting perfectly into the workflow of modern, automated Japanese barns.
Ensuring Quality, Reliability, and Scientific Excellence since 2005.
Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys), established in 2005, is a premier manufacturer in the animal pharmaceutical industry with a registered capital of 30 million RMB. Our state-of-the-art facility includes specialized workshops for powders, premixes, injections, oral solutions, and specifically, our high-demand intramammary infusions.
Vetsys operates in full compliance with strict Good Manufacturing Practices (GMP). By 2015, we became one of the top animal pharmaceutical producers in China, with domestic sales exceeding USD 20 million, and we are now a key exporter to the Japanese and global markets.
At Vetsys, innovation is our core differentiator. We have established an independent research institute staffed by world-class scientists. Our team works tirelessly to adapt to evolving market demands, ensuring our intramammary infusions remain effective against emerging bacterial strains.
Quality is the cornerstone of our operations. Every batch undergoes extensive control checks before reaching the market. Furthermore, we are committed to sustainability, investing in green technologies to minimize our environmental footprint while promoting animal well-being.
Precision Engineering for Veterinary Medicine
In Japan, the protocol for mastitis involves rapid identification and treatment. Our Compound Amoxicillin Intramammary Infusion is particularly effective in Japanese herds where Staphylococcus aureus or Streptococcus uberis is detected. The addition of Prednisolone helps in reducing udder edema, allowing the cow to return to the milking line faster, which is critical for maintaining the high-frequency milking schedules typical in Japan.
Utilizing Ampicillin and Cloxacillin formulations to provide long-acting protection during the non-lactating phase, preventing new infections in the next cycle.
High-absorption Cefquinome Sulfate treatments designed to clear clinical mastitis symptoms within 48-72 hours with controlled withdrawal periods.
GMP & ISO certified intramammary infusions for professional veterinary use.
Through continuous innovation and a commitment to global standards, Vetsys remains the trusted partner for Japan's livestock industry. Our focus on quality management and research ensures that we deliver not just medicines, but comprehensive health solutions for a sustainable dairy future.
Top 10 Manufacturer
Global Export Expertise
GMP Certified Quality
